Reimbursement Scheme Jardiance® - Chronic Kidney Disease
Arrangement for reimbursement by TerugBetaalRegeling Jardiance® (empagliflozin) 10 mg for patients with chronic kidney disease...
Update Reimbursement Scheme Forxiga® - HFpEF
TerugBetaalRegeling Forxiga® (dapagliflozin) 10 mg for patients with symptomatic chronic heart failure with a LVEF ≥ 40% (HFmrEF &...
Reimbursement Scheme Signifor®
The health insurer does not fully reimburse Signifor® 20mg. The producer of this medicine has therefore asked TBR Nederland to...
Update TerugBetaalRegeling Veltassa®, patiromer 8.4g
From May 1, 2023, the use of Veltassa® 8.4g will be fully reimbursed by the health insurer. For this reason the Reimbursement...
Update Reimbursement Scheme Jardiance®
From April 1, 2023, the use of Jardiance® (empagliflozin) in patients with chronic heart failure regardless of ejection fraction...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine